Go Deep
VivoSim Labs, Inc.
VivoSim Labs, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -17,156 | -0.0 | -1.21 | -0.41 | 16.20 |
| Oct 2026 | -17,086 | -0.0 | -1.11 | -0.41 | 14.86 |
| Oct 2026 | -19,289 | -0.0 | -1.11 | -0.41 | 14.93 |
| Oct 2026 | -19,358 | -0.0 | -1.21 | -0.41 | 16.24 |
| Oct 2026 | -19,386 | -0.0 | -1.25 | -0.41 | 16.74 |
| Oct 2026 | -19,298 | -0.0 | -1.13 | -0.41 | 15.05 |
VivoSim Labs, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 18,000.0 | 40,000.0 | 26,000.0 | 28,000.0 |
| Net Profit | -1,338,000.0 | -5,764,000.0 | -2,691,000.0 | -2,545,000.0 |
| EPS | -0.2 | — | -1.0 | -1.0 |
VivoSim Labs, Inc. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 131,000.0 | 144,000.0 | 109,000.0 | 370,000.0 | — |
| Net Profit | -13,843,000.0 | -2,488,000.0 | -14,671,000.0 | -17,259,000.0 | — |
| EPS | -5.3 | -1.7 | -19.2 | -23.8 | — |
VivoSim Labs, Inc. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 7,386,000.0 | 14,650,000.0 | 6,349,000.0 | 20,313,000.0 | — |
| Total Liabilities | 8,485,000.0 | 4,158,000.0 | 2,748,000.0 | 4,984,000.0 | — |
| Total Equity | -1,099,000.0 | 10,492,000.0 | 3,601,000.0 | 15,329,000.0 | — |
Owes vs Owns
VivoSim Labs, Inc. owed $1.61 for every $1 it owned in Jun 2026, up from $0.25 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.61× | 1.15× | 0.28× | 0.43× | 0.25× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
VivoSim Labs, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Mar 2026
Cash & short-term investments 68.0%Receivables 14.2%Fixed assets (tangible) 8.3%Other assets 9.5%
How it's funded — Mar 2026
Short-term debt 5.3%Payables 12.0%Other liabilities 82.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 5.0 | 11.3 | 2.9 | 16.0 |
| Receivables | 1.0 | 0.0 | 0.0 | 0.2 |
| Inventory | 0.0 | 0.0 | 0.3 | 0.0 |
| Fixed assets (tangible) | 0.6 | 1.3 | 2.0 | 2.6 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.7 | 2.0 | 1.1 | 1.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.4 | 0.5 | 0.5 | 0.5 |
| Long-term debt | 0.0 | 0.4 | 0.9 | 1.3 |
| Payables | 1.0 | 1.6 | 0.6 | 0.3 |
| Other liabilities | 7.0 | 1.6 | 0.7 | 2.8 |
| Shareholders' equity | -1.1 | 10.5 | 3.6 | 15.3 |
| Net tangible assets | -1.1 | 10.5 | 3.6 | 15.3 |
VivoSim Labs, Inc. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -10,827,000.0 | -9,461,000.0 | -14,653,000.0 | -12,408,000.0 | — |
| Investing Activities | 94,000.0 | 9,025,000.0 | 816,000.0 | -966,000.0 | — |
| Financing Activities | 4,445,000.0 | 8,847,000.0 | 1,437,000.0 | 0.0 | — |